Lv5
1390 积分 2021-05-11 加入
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2天前
已完结
Treatment sequences in EGFR mutant advanced NSCLC
2天前
已完结
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort
3天前
已完结
Validation and benchmarking of targeted panel sequencing for cancer genomic profiling
24天前
已完结
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709X
24天前
已完结
Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer
1个月前
已完结
Validation and benchmarking of targeted panel sequencing for cancer genomic profiling
2个月前
已完结
Minimal residual disease in solid tumors: an overview
2个月前
已完结
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel
2个月前
已完结
Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia
2个月前
已完结
皖公网安备34019202002308
